1. Morpurgo E, Galandiuk S. Fournier's gangrene. Surg Clin North Am. 2002. 82:1213–1224.
Article
2. Smith GL, Bunker CB, Dinneen MD. Fournier's gangrene. Br J Urol. 1998. 81:347–355.
Article
3. Eke N. Fournier's gangrene: a review of 1726 cases. Br J Surg. 2000. 87:718–728.
Article
4. Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack CD, Wessells H. Fournier's Gangrene: population based epidemiology and outcomes. J Urol. 2009. 181:2120–2126.
Article
5. Paty R, Smith AD. Gangrene and Fournier's gangrene. Urol Clin North Am. 1992. 19:149–162.
Article
6. Norton KS, Johnson LW, Perry T, Perry KH, Sehon JK, Zibari GB. Management of Fournier's gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment. Am Surg. 2002. 68:709–713.
7. Uluğ M, Gedik E, Girgin S, Celen MK, Ayaz C. The evaluation of microbiology and Fournier's gangrene severity index in 27 patients. Int J Infect Dis. 2009. 13:e424–e430.
Article
8. Kuo CF, Wang WS, Lee CM, Liu CP, Tseng HK. Fournier's gangrene: ten-year experience in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2007. 40:500–506.
9. Kim BH, Chang HS, Park CH, Kim CI, Kim KS. Necessity of aggressive management in Fournier's gangrene. Korean J Urol. 2004. 45:793–799.
10. Kim SK, Park JI, Joo YT, Park ST, Ha WS, Hong SC, Lee YJ, Jung EJ, Jeung CY, Choi SK. Fournier's gangrene: clinical analysis of 11 patients. J Korean Surg Soc. 2006. 71:274–279.
11. Lim SD, Lee SJ, Jeong HJ. The study of prognostic factors in fournier's gangrenes. Korean J Urol. 2002. 43:412–417.
12. Piscitelli SC, Shwed J, Schreckenberger P, Danziger LH. Streptococcus milleri group: renewed interest in an elusive pathogen. Eur J Clin Microbiol Infect Dis. 1992. 11:491–498.
13. Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM.
Streptococcus intermedius,
Streptococcus constellatus, and
Streptococcus anginosus (the
Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol. 1992. 30:243–244.
Article
14. Claridge JE 3rd, Attorri S, Musher DM, Hebert J, Dunbar S. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess. Clin Infect Dis. 2001. 32:1511–1515.
15. Han WJ, Cho MS, Lee JH, Ahn HD, Yoon KH, Seo JG, Kim JY, Kim SY, Park YS, Seo YH, Cho YK. A case of humeral osteomyelitis and soft tissue abscess accompanied with
Streptococcus anginosus bacteremia. Infect Chemother. 2008. 40:281–283.
Article
16. Bantar C, Fernandez Canigia L, Relloso S, Lanza A, Bianchini H, Smayevsky J. Species belonging to the "
Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens. J Clin Microbiol. 1996. 34:2020–2022.
Article
17. Tracy M, Wanahita A, Shuhatovich Y, Goldsmith EA, Clarridge JE 3rd, Musher DM. Antibiotic susceptibilities of genetically characterized
Streptococcus milleri group strains. Antimicrob Agents Chemother. 2001. 45:1511–1514.
Article
18. Levenson RB, Singh AK, Novelline RA. Fournier gangrene: role of imaging. Radiographics. 2008. 28:519–528.
Article